Acetazolamide is a sulfonamide derivative; blood disorders, rashes, and other sulfonamide-related side-effects occur occasionally — patients should be told to report any unusual skin rash
unpleasant breath odor
The loss of cerebral blood flow leads to reduced oxygen and glucose supply and a subsequent switch to the glycolytic pathway Abstract SUMMARY: The acetazolamide (ACZ) challenge test is a useful clinical tool and a reliable predictor of critically reduced perfusion
Acetazolamide augmented interhemi-spheric asymmetry of cerebral blood flow in patients with unilateral occlusion of major cerebral arteries, whereas no significant side-to-side
Several investigators have shown that acetazolamide causes an increase in cerebral blood flow
Cerebral vasoreactivity assessed with transcranial Doppler and regional cerebral blood flow
Objective
Kuwabara Y, Ichiya Y, Sasaki M, oshida T, Masuda K